Health Guide
Compound Library
Plain-English summaries: what it is, what it was studied for, safety and regulatory status, plus mixing and dosing charts.
An FDA-approved prescription peptide that activates both GIP and GLP-1 receptors.
The active ingredient in several FDA-approved GLP-1 medicines.
An FDA-approved prescription peptide that reduces excess abdominal (visceral) fat in adults with HIV-associated lipodystrophy.
Bremelanotide is the active ingredient in Vyleesi, FDA approved in 2019 for a specific form of low sexual desire in premenopausal women.
A four-amino-acid peptide that targets mitochondria. In September 2025 the FDA granted accelerated approval to Forzinity (elamipretide) for muscle strength in Barth syndrome, a rare genetic disorder.
"191AA" just describes the 191-amino-acid human growth hormone molecule; somatropin is the recombinant prescription version.
A pregnancy hormone with specific prescription uses in fertility care and some hormone conditions.
A peptide hormone with established hospital uses in childbirth and a much less settled role in research on social behavior, appetite and sexual function.
A synthetic alpha-MSH analogue. As the Scenesse implant (afamelanotide), it is FDA approved for a rare light-sensitivity disorder, not for cosmetic tanning.
An amino-acid derivative the body uses to move fatty acids into mitochondria for energy.
A prescription fertility medicine that supplies both FSH and LH activity.
An FDA-approved prescription medicine that builds bone in people with osteoporosis at high fracture risk.
An FDA-approved prescription bone-building medicine for osteoporosis in adults at high fracture risk.